clinical trial Archive — Page 3 of 16

November 11, 2025

AI recruited to lower leading cause of preventable hospital deaths

Risk of VTE rises in hospitals due to factors such as patient immobility, effects from major surgery, and use of indwelling medical devices like central lines.

(iStock image)
November 4, 2025

VUMC performs minimally invasive transcatheter tricuspid valve replacement for recent heart transplant recipient

The team used an artificial tricuspid valve, EVOQUE, which received Food and Drug Administration approval in February.

October 22, 2025

Behind the curtain: Secrets of the volatile, delusional brain 

The VUMC approach, based on the “Feeling Safe Program” developed by British psychologist Daniel Freeman, targets specific factors that contribute to persecutory delusions, including worry, safety behaviors, avoidance and hallucinations (such as hearing voices).

September 12, 2025

Study shows magnesium inhibits colorectal cancer carcinogenesis by increasing vitamin D-synthesizing bacteria  

The findings from the current study suggest that magnesium also increases the gut synthesis of vitamin D, which does not go to the blood and takes effect locally.

August 1, 2025

Study reports final clinical trial data for advanced kidney cancer treatment

The drug combo pembrolizumab plus axitinib had sustained and durable clinical benefit in more than five years of follow-up. It is a standard-of-care first-line treatment for advanced kidney cancer.

July 22, 2025

Study provides new data on COVID outcomes for cancer patients 

Death incidence was highest in patients with lymphoma, intermediate in patients with acute leukemia and lung cancer, and lowest in patients with other solid tumors or with blood cancers other than lymphoma.